Neuromodulation for Tourette syndrome: current techniques and future perspectives

Tourette syndrome (TS) is a chronic tic disorder characterized by motor and vocal tics. Neuropsychiatric symptoms are nearly universal in TS, particularly attention deficit hyperactivity disorder and obsessive-compulsive disorder. TS can have substantial effects on quality of life, social and intellectual development, opportunities, relationships, and more. Treatment options are limited; the most common being behavioral therapy and pharmacological interventions, such as antipsychotics and anti-adrenergic agents, often yielding unsatisfactory benefits. Neuromodulation, the alteration of neural pathways and networks under external stimulation, has been established as a viable treatment strategy for specific aspects of TS. Several neuromodulation techniques have been utilized, with deep brain stimulation (DBS) exhibiting the strongest efficacy at around 50% reduction of tics on average across cohorts. However, the invasive nature of DBS remains a disincentive for its uptake, as well as the natural reduction in tic severity for many TS individuals as they enter adulthood. Less-invasive neuromodulation has also been explored, but efficacy remains limited. Given its effectiveness in TS, DBS provides the unique opportunity to record neural activity from deep brain structures, which has been used to investigate underlying pathophysiology and search for biomarkers of treatment response. These insights may guide strategies for less invasive neuromodulation. In this narrative review, we aim to discuss currently utilized neuromodulation therapies for the treatment of TS, as well as propose potential future strategies. Additionally, we discuss how to maximize progress in the field, including crucial multicenter data sharing, utilization of recording capabilities on DBS devices, correlation with the precise location of implanted electrodes, and harnessing pre-clinical studies for a more parameterized understanding of TS neuromodulation. These techniques will enable a clearer understanding of TS and the mechanisms behind successful treatment. This could lead to advanced therapies that improve the quality of life for individuals with TS.

Authors

Institutions

Publication Details

Journal
Journal of Neural Engineering
Published
2025-10-13
DOI
https://doi.org/10.1088/1741-2552/ae1257
Primary Topic
Obsessive-Compulsive Spectrum Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Neuromodulation for Tourette syndrome: current techniques and future perspectives

Collin J. Anderson, Daria Anderson, Kara A. Johnson, Neil Mahant et al.
Journal of Neural Engineering
Obsessive-Compulsive Spectrum Disorders
article

Neuromodulation for Tourette syndrome: current techniques and future perspectives

Collin J. Anderson, Daria Anderson, Kara A. Johnson, Neil Mahant, Sarah Haslam
article en

Abstract

Tourette syndrome (TS) is a chronic tic disorder characterized by motor and vocal tics. Neuropsychiatric symptoms are nearly universal in TS, particularly attention deficit hyperactivity disorder and obsessive-compulsive disorder. TS can have substantial effects on quality of life, social and intellectual development, opportunities, relationships, and more. Treatment options are limited; the most common being behavioral therapy and pharmacological interventions, such as antipsychotics and anti-adrenergic agents, often yielding unsatisfactory benefits. Neuromodulation, the alteration of neural pathways and networks under external stimulation, has been established as a viable treatment strategy for specific aspects of TS. Several neuromodulation techniques have been utilized, with deep brain stimulation (DBS) exhibiting the strongest efficacy at around 50% reduction of tics on average across cohorts. However, the invasive nature of DBS remains a disincentive for its uptake, as well as the natural reduction in tic severity for many TS individuals as they enter adulthood. Less-invasive neuromodulation has also been explored, but efficacy remains limited. Given its effectiveness in TS, DBS provides the unique opportunity to record neural activity from deep brain structures, which has been used to investigate underlying pathophysiology and search for biomarkers of treatment response. These insights may guide strategies for less invasive neuromodulation. In this narrative review, we aim to discuss currently utilized neuromodulation therapies for the treatment of TS, as well as propose potential future strategies. Additionally, we discuss how to maximize progress in the field, including crucial multicenter data sharing, utilization of recording capabilities on DBS devices, correlation with the precise location of implanted electrodes, and harnessing pre-clinical studies for a more parameterized understanding of TS neuromodulation. These techniques will enable a clearer understanding of TS and the mechanisms behind successful treatment. This could lead to advanced therapies that improve the quality of life for individuals with TS.

Journal of Neural EngineeringVol. 22(6)
The University of Sydney (AU), University of Florida Health (US), Westmead Hospital (AU), University of Florida (US), Florida College (US)
Openalex Percentile: Top 60%
Obsessive-Compulsive Spectrum Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.